Trial Profile
A study of long-segment stents in patients with coronary artery diseases treated with everolimus-eluting bioresorbable vascular scaffolds
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 23 Dec 2015 New trial record